DRKS00026732招募中未知
Prospective, controlled immunhistological analysis of soft tissue graft with acelullar porcine dermal matrix above dental implants
niversitätsklinik für Zahn, Mund- und Kieferheilkunde Klinik für Mund-, Kiefer- und Gesichtschirurgie0 个研究点目标入组 40 人开始时间: 2021年10月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomized controlled study
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •1) Patients who receive an implant treatment due to a medical indication with soft tissue augmentation (with NovoMatrix) or without soft tissue augmentation at the same time as implantation.
- •2) People over the age of 18 in the sense of the age of majority, as well as full legal capacity (§§ 2 BGB).
- •3) Non-smokers and moderate smokers = 20 cigarettes / day
- •4) Good oral hygiene and plaque control of the patient (full mouth plaque score = 25%)
- •5) The patient that was informed about the follow-up examinations and agrees to participate in them.
排除标准
- •1) Dependent persons or persons in custody
- •2) General diseases that contradict dental implant therapy (e.g. diabetes mellitus not ceased)
- •3) Previous history of non-compliance and / or unreliability)
- •4) Diseases of the mucous membrane (e.g. erosive lichen planus)
- •5) Untreated endodontic or periodontal lesions with probing of the PD of = 4mm directly adjacent to the planned implant position
- •6) Patients with inadequate oral hygiene (full mouth plaque score> 25%) or gingivitis
- •6) Heavy nicotine abuse (> 20 cigarettes / day) or consumption of chewing tobacco
- •7) Pregnant or breastfeeding women
研究者
相似试验
已完成
3 期
Human Papilloma Virus (HPV) Vaccination in Special Risk GroupsSpecial Risk Groups1. Paediatric Rheumatalogical Disease2. Inflammatory Bowel Disease3. Acute Lymphoblastic Leukaemia4. Solid Organ Transplant Recipients (kidney and liver)5. Chronic Renal Disease6. Bone Marrow TranssplantThe response to the HPV vaccine will be studied within these 6 special risk groups.Special Risk Groups1. Paediatric Rheumatalogical Disease2. Inflammatory Bowel Disease3. Acute Lymphoblastic Leukaemia4. Solid Organ Transplant Recipients (kidney and liver)5. Chronic Renal Disease6. Bone Marrow TranssplantThe response to the HPV vaccine will be studied within these 6 special risk groups.Inflammatory and Immune System - Other inflammatory or immune system disordersACTRN12609000571279ational Health and Medical Research Council & Clinical Centre of Research Excellence(NHMRC CCRE) in Childhood and Adolescent Immunisation100
进行中（未招募）
1 期
Administration of 9valent vaccine against papillomavirus in HIV-positive womeEUCTR2018-000228-33-BECHU Saint-Pierre200
进行中（未招募）
不适用
Klinische Studie zur Überprüfung der Immunogenität unterschiedlicher Varianten einer FSME-Schnellimmunisierung mit inaktiviertem Frühsommer-Meningoenzephalitis-Impfstoff - FSME-Schnellimmunisierungs-StudieEUCTR2006-006955-10-ATniv.-Prof. Dr. Helmut Mittermayer108
已完成
不适用
Prospective cohort study on immunogenicity, safety and efficacy of seasonal influenza vaccination to healthy adults who received non-adjuvanted or AS03A-adjuvanted pandemic influenza H1N1 vaccination one year agoJPRN-UMIN000004631ational Hospital Organization, Tokyo National Hospital100
已完成
4 期
Influenza Specific Immunity After Vaccination in Recipients of Haematopoietic Stem Cell Transplantation Compared to Healthy ControlsHaematopoietic Stem Cell Transplant patientshaematological malignancyAutologous or allogeneicCancer - Any cancerInfection - Other infectious diseasesInflammatory and Immune System - Other inflammatory or immune system disorderscancerInfluenzaACTRN12614000240640Princess Margaret Hospital for children150